Quilar, Ariel G.
HRN: 21-88-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/11/2022
09/18/2022
IV
1.5g
Q8hrs
Multiple Lacerated Wound R Forehead, Avulsed Wound Nasolabial Area, T/C Mild TBI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes